Previous close | 0.9200 |
Open | 0.9000 |
Bid | 0.9400 x 900 |
Ask | 0.9400 x 1200 |
Day's range | 0.9000 - 0.9800 |
52-week range | 0.8110 - 4.8800 |
Volume | |
Avg. volume | 282,284 |
Market cap | 12.483M |
Beta (5Y monthly) | 0.99 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
After losing some value lately, a hammer chart pattern has been formed for Monopar Therapeutics Inc. (MNPR), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
Monopar Therapeutics Inc. (MNPR) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...
Monopar Therapeutics (MNPR) surges after it reports data from its ongoing phase Ib dose escalation study evaluating camsirubicin for treating soft-tissue sarcoma.
Just because a business does not make any money, does not mean that the stock will go down. For example, although...
After losing some value lately, a hammer chart pattern has been formed for Monopar Therapeutics Inc. (MNPR), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.